The founder of Linkedin, REID HOFFMAN and Siddhartha Mukherjee, co -founded Manas AI, a cancer researcher, the author of the “The Emper of All Maladies”, and a startup of drug discovery driven by AI. 。 Initially, the company, focusing on breast cancer, prostate cancer, and lymphoma, raised $ 24.6 million in Hoffman, total catalyst, and Gray Rock.
The Capital of Manas AI is pale compared to some other startups trying to develop new drugs using AI models. Last year, XAIRA argued that it was ready to start the development of drugs, and was launched in large quantities of $ 1 billion with the first funding. ENDPTS reported that TreeLine BIOSCIENCES is another company that uses AI for drug discovery and collected $ 422 million last year.
Manas AI has designed a molecular molecules with AI and claims that it will test with wet labs, and it is reported that Hoffman stated in his new book “SuperAgency” presentation. Manas states that it will develop new pharmaceuticals using Microsoft's cloud computing platform, Microsoft Azure and Microsoft's “AI Deep Domain Knowledge”.
Hoffman has a close relationship with Microsoft. Microsoft acquired the previous company, Linkedin, is famous for its 2016 huge hit.